LifeStance Health Group, Inc. (NASDAQ: LFST) is a Healthcare company (Medical - Care Facilities) with a market capitalization of $5.4B. The Maz Rating grades it against the other companies in its sector.
LifeStance Health Group, Inc.'s current Maz Rating and its five factor grades are for members: log in to see them.
At $14.24, LifeStance Health Group, Inc. trades at 76.1x trailing earnings, 3.3x sales and 3.7x book value, with an EV/EBITDA of 36.9. Over the last twelve months it generated about $1.6B of revenue and $71M of net income. It runs a gross margin of 34.4%, an operating margin of 6.2% and a net margin of 4.3%. It shows return on equity of 4.8%, return on invested capital of 4.2% and a free cash flow yield of 3.3%. On the balance sheet: a debt-to-equity ratio of 0.31 and a current ratio of 1.44. Over the past 52 weeks the share price ranged from $6.01 to $15.66, with a beta of 1.30.
LifeStance Health Group, Inc. does not currently pay a dividend.
11 Wall Street analyst ratings cover the stock: 9 Buy and 2 Hold, for a Buy consensus. This is the sell side's view, separate from the Maz Rating.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.